Five of the nation’s largest health systems are forming a nonprofit generic drug company to take on one of the biggest challenges hospitals face today: the persistent shortages and spiraling costs of injectable generic medicines.
The goal of the new company is to use the enormous purchasing power of the five health systems’ hundreds of hospitals—plus that of others who have expressed interest in joining since the January announcement—as a bulwark against